# C4 Therapeutics, Inc. (CCCC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CCCC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 12.79M | $ -48.76M | $ -31.62M | $ 56.86M | $ 247.27M |
| 2025 | $ 36.81M | $ -107.50M | $ -101.68M | $ 59.98M | $ 256.59M |
| 2024 | $ 37.40M | $ -110.70M | $ -68.67M | $ 65.76M | $ 215.99M |
| 2023 | $ 22.44M | $ -143.26M | $ -117.37M | $ 70.98M | $ 246.11M |
| 2022 | $ 34.74M | $ -143.19M | $ -124.48M | $ 87.15M | $ 289.23M |
| 2021 | $ 54.42M | $ -99.72M | $ -104.89M | $ 42.88M | $ 389.61M |
| 2020 | $ 42.29M | $ -84.51M | $ -86.50M | $ 22.92M | $ 280.79M |
| 2019 | $ 27.60M | $ -49.43M | $ 70.04M | $ 13.75M | $ -111.96M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.23 |
| Liabilities / Eq | 0.45 |
| Current Ratio | 5.45 |

## Other views

- [Metrics](https://sponda.capital/en/CCCC.md)
- [Charts](https://sponda.capital/en/CCCC/charts.md)
- [Compare](https://sponda.capital/en/CCCC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.